PeptiDream Inc. (TYO:4587)
1,516.50
-42.00 (-2.69%)
At close: Feb 6, 2026
PeptiDream Market Cap
PeptiDream has a market cap or net worth of 195.95 billion as of February 6, 2026. Its market cap has decreased by -34.01% in one year.
Market Cap
195.95B
Enterprise Value
183.11B
Revenue
17.93B
Ranking
n/a
PE Ratio
n/a
Stock Price
1,516.50
Market Cap Chart
Since June 11, 2013, PeptiDream's market cap has increased from 74.10B to 195.95B, an increase of 164.46%. That is a compound annual growth rate of 7.98%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 6, 2026 | 195.95B | -8.45% |
| Dec 30, 2025 | 214.04B | -37.55% |
| Dec 30, 2024 | 342.76B | 77.91% |
| Dec 29, 2023 | 192.66B | -28.55% |
| Dec 30, 2022 | 269.66B | -18.39% |
| Dec 30, 2021 | 330.41B | -49.84% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| SanBio Company | 148.50B |
| GNI Group | 139.73B |
| Takara Bio | 96.69B |
| Nxera Pharma | 75.02B |
| Cuorips | 68.55B |
| Oncolys BioPharma | 50.53B |
| Healios K.K. | 43.17B |
| RaQualia Pharma | 26.40B |